Abstract:Backgroundand objectives Rheumatoid arthritis (RA) is an autoimmune disease affecting about 1% of the population. Though of unknown aetiology, it is considered to have a strong genetic influence, resulting in the activation of different immune cells and consequent bone and cartilage destruction of the joints. The production of anticollagen type II (CII) antibodies is a common feature between RA patients and the collagen-induced arthritis (CIA) mouse model. Understanding how distinct anti-CII epitopes are genetically selected could benefit the development of new RA therapies. Here, the authors assess the genetic influence of specific anti-CII antibody production in a mouse model of RA. Material and methods In this particular study, the authors have used as genetic variance tool a heterogeneous stock (HS) mice cohort of eight inbred mouse strains. Three of the major anti-CII B cell epitopes (C1, U1 and J1) were analysed by ELISA. Sequencing of the genes coding for the M2139 monoclonal antibody (J1-specific mAb) was additionally done for all the HS strains. Results A genome wide study of antibody response during CIA development suggested that specific anti-CII antibodies are regulated by the immunoglobulin heavy chain locus (IgH). The haplotype reconstruction analysis showed a preference for the anti-J1 antibody production by certain mouse strains, in detriment of anti-C1 antibodies. The authors thus hypothesised that the selection of particular IgHv genes is responsible for this J1 versus C1 epitope selection. Preliminary sequencing data of the genes coding for the M2139 monoclonal antibody in all the HS strains, supports the initial hypothesis. The difference relies on an amino acid change from a hydrophobic tryptophan to a polar amino acid (eg, threonine) in the CDR1 region. Three-dimensional structure of M2139 Fab with triple helical J1 peptide shows that the tryptophan in the CDR1 region of the heavy chain is contacting with a hydrophobic leucine amino acid in the J1 epitope. This interaction may be essential for recognition of the J1 epitope. Replacement of Trp by Thr in this position could abrogate the binding to J1 epitope. Conclusions CIA development in HS mice allowed for a genome wide study on anti-CII specific responses. The data revealed a genetic association with the production of anti-J1 antibodies. Sequencing of the genes coding for the anti-J1 mAb reveal an amino acid substitution influencing the polarity within the CDR1 region. Cloning and expression of these mutations and consequent anti-J1 binding properties will further on confirm or reject our hypothesis.

Association Between Protein Tyrosine Phosphatase 22 Variant R620W in Conjunction with the HLA-DRB1 Shared Epitope and Humoral Autoimmunity to an Immunodominant Epitope of Cartilage-Specific Type II Collagen in Early Rheumatoid Arthritis.

The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status

Non-HLA Genes PTPN22, CDK6 and PADI4 Are Associated with Specific Autoantibodies in HLA-defined Subgroups of Rheumatoid Arthritis.

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

Multifunctional T Cell Reactivity to Native and Glycosylated Type-II Collagen in Rheumatoid Arthritis.

Genetic Influence of Specific Anticollagen Antibody Production in A Mouse Model of Rheumatoid Arthritis

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor

A Novel Hla-Drb1*10:01-Restricted T Cell Epitope from Citrullinated Type Ii Collagen Relevant to Rheumatoid Arthritis

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

Humoral Immune Response to Citrullinated Collagen Type II Determinants in Early Rheumatoid Arthritis

Definition of Mhc and T Cell Receptor Contacts in the Hla-Dr4-Restricted Immunodominant Epitope in Type Ii Collagen and Characterization of Collagen-Induced Arthritis in Hla-Dr4 and Human Cd4 Transgenic Mice

Epitope-specific Antibody Response is Controlled by Immunoglobulin V(H) Polymorphisms.

[Proliferation of Type II Collagen Specific T Cell Response and Antibody Formation in Rheumatoid Arthritis and Their Relations to HLA-DR4].

Class Ii Major Histocompatibility Complex-Associated Response to Type Xi Collagen Regulates the Development of Chronic Arthritis in Rats

Positional Identification of RT1-B (HLA-DQ) As Susceptibility Locus for Autoimmune Arthritis.

Type-II Collagen in the Pathogenesis of Rheumatoid Arthritis

A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22

Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.

Cartilage-Specific Autoimmunity in Rheumatoid Arthritis: Characterization of A Triple Helical B Cell Epitope in the Integrin-Binding-Domain of Collagen Type Ii

Collagen Type Ii Is Recognized By A Pathogenic Antibody Through Germline Encoded Structures

[PTPN22 1858C/T Polymorphism is Associated with Rheumatoid Arthritis Susceptibility in Caucasian Population: a Meta-Analysis].